Strides’ New CEO Is Former Cipla COO

Strides Names R Ananthanarayanan To Replace Arun Kumar As CEO

Arun Kumar is stepping down as chief executive of Strides Pharma to focus on overall corporate strategy and the company’s return to injectables. He will be replaced by former Cipla chief operating officer R Ananthanarayanan.

Cipla COO Dr R Ananthanarayanan
New Strides CEO R Ananthanarayanan Recently Stepped Down As Cipla COO

Strides’ founder Arun Kumar is quitting as the generics firm’s chief executive to focus on overall corporate strategy and on the firm’s reborn injectables business which he sees as a hugely lucrative opportunity.

Kumar will stay on as Strides’ chairman. But replacing him as CEO and managing director will be R Ananthanarayanan –...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin